A Flood of New, Deadlier Drugs
Episode
27 min
Read time
2 min
Topics
Health & Wellness, Fundraising & VC, Software Development
AI-Generated Summary
Key Takeaways
- ✓Synthetic drug proliferation: The number of new psychoactive substances has tripled in the last decade, reaching 1,450 distinct compounds. Because all are lab-synthesized, chemists can alter a single molecule to produce an entirely new drug, making each regulatory crackdown on one substance a direct catalyst for the next generation of replacements.
- ✓Nitazines threat: Nitazines — a class of opioids developed by a Swiss pharmaceutical company in the 1950s but never commercialized — are now being manufactured illicitly in at least a dozen variants. They are 20–40 times more potent than fentanyl and are spreading across the U.S. and Europe, particularly where fentanyl supply has been tightly restricted by enforcement.
- ✓Drug-soaked paper as smuggling method: Traffickers dissolve synthetic drugs into liquid, saturate sheets of paper, and mail them into jails. Cook County investigators found a single sheet containing 10 overlapping synthetic substances. Smugglers later exploited Amazon's third-party seller system to ship drug-soaked books directly to inmates through trusted retail packaging, bypassing standard screening.
- ✓Enforcement paradox: Supply-side crackdowns consistently accelerate drug innovation rather than reduce availability. When authorities pressured Chinese manufacturers and Mexican cartels over fentanyl precursors, producers shifted to nitazines. After Cook County arrested its largest drug-soaked paper supplier, overdose rates remained unchanged within months, and a substance five times more potent appeared shortly after.
- ✓Harm reduction as viable framework: Scientists and public health experts increasingly favor harm reduction over criminalization or broad decriminalization, particularly given that 1,400-plus substances have no established medical safety profiles. Practical measures include widespread Narcan distribution, needle exchange programs, and legal immunity for bystanders who call emergency services during an overdose — all aimed at reducing deaths without requiring supply elimination.
What It Covers
NYT reporter Azam Ahmed examines how synthetic drugs — now numbering 1,450 distinct substances — are replacing plant-based narcotics. Fentanyl is already being superseded by nitazines, which are 20–40 times more potent. Ahmed's investigation into Cook County Jail reveals how drug-soaked paper has become a primary smuggling vector inside U.S. correctional facilities.
Key Questions Answered
- •Synthetic drug proliferation: The number of new psychoactive substances has tripled in the last decade, reaching 1,450 distinct compounds. Because all are lab-synthesized, chemists can alter a single molecule to produce an entirely new drug, making each regulatory crackdown on one substance a direct catalyst for the next generation of replacements.
- •Nitazines threat: Nitazines — a class of opioids developed by a Swiss pharmaceutical company in the 1950s but never commercialized — are now being manufactured illicitly in at least a dozen variants. They are 20–40 times more potent than fentanyl and are spreading across the U.S. and Europe, particularly where fentanyl supply has been tightly restricted by enforcement.
- •Drug-soaked paper as smuggling method: Traffickers dissolve synthetic drugs into liquid, saturate sheets of paper, and mail them into jails. Cook County investigators found a single sheet containing 10 overlapping synthetic substances. Smugglers later exploited Amazon's third-party seller system to ship drug-soaked books directly to inmates through trusted retail packaging, bypassing standard screening.
- •Enforcement paradox: Supply-side crackdowns consistently accelerate drug innovation rather than reduce availability. When authorities pressured Chinese manufacturers and Mexican cartels over fentanyl precursors, producers shifted to nitazines. After Cook County arrested its largest drug-soaked paper supplier, overdose rates remained unchanged within months, and a substance five times more potent appeared shortly after.
- •Harm reduction as viable framework: Scientists and public health experts increasingly favor harm reduction over criminalization or broad decriminalization, particularly given that 1,400-plus substances have no established medical safety profiles. Practical measures include widespread Narcan distribution, needle exchange programs, and legal immunity for bystanders who call emergency services during an overdose — all aimed at reducing deaths without requiring supply elimination.
Notable Moment
Ahmed describes a Cook County inmate who had stopped using drug-soaked paper but resumed during a holiday lockdown. The inmate explained that getting high made him stop caring about going home — capturing how incarceration's psychological weight drives use toward substances that are potentially lethal.
Episode Transcript
Brought to you by the Capital One Savor card. With Savor, you earn unlimited 3% cash back on dining, entertainment, and at grocery stores. That's unlimited cash back on ordering takeout from home or unlimited cash back on tickets to concerts and games. So grab a bite, grab a seat, and earn unlimited 3% cashback with the Sabre card. Capital One. What's in your wallet? Terms apply. See capital1.com for details. From the New York Times, I'm Natalie Kitroweth. This is The Daily. Just as America is beginning to wrap its arms around the fentanyl crisis, a new kind of drug epidemic is emerging. It's faster, more addictive, and far more lethal. And what's driving it are new types of synthetic drugs, substances that can be made almost anywhere, altered endlessly, trafficked easily, and then consumed in just about any form imaginable. Today, my colleague, Azem Ahmed, explains how these deadlier drugs are beginning to take hold and brings us inside one effort to do something about it. It's Tuesday, May 26. Azem, welcome to The Daily. It's wonderful to have you here in New York. Well, thank you for having me. You are here not only because you have won multiple awards for your investigations. This is true. You can't deny it. Not only because you are, I think it's fair to say, a foreign correspondent's foreign correspondent, but because you are in the middle of truly mind blowing reporting on the new world of synthetic drugs. And I think this is something that none of us, even me, who, you know, I have a special interest reporting experiences Yeah. In this world really understood until you started to break these stories. So I wanna just start with how you got to this. What drew you in to these stories? You know, obviously, we work together in Mexico. And in Mexico, you're constantly looking at the repercussions of the war on drugs. Yep. You're looking at countless lives lost. You're looking at, you know, inordinate amounts of drugs, fentanyl moving north into The United States. You kinda see the mechanism of failure up close, and we all know the war on drugs has failed. We also know, like, it not only failed, it kinda made things worse. And you realize fentanyl, meth, two of the first sort of synthetic drugs were out there. Basically, they were harbingers of this sort of dystopian future that is upon us. For most of human history, drugs have been grown in the land. Yeah. You know, when the war on drugs was first declared by president Nixon, there was cocaine, marijuana, heroin. Yep. The big ones. Now there's, like, 1,450 new psychoactive substances. These are Is that a real stat? That's a real stat. Yikes. It's gone up like it's tripled in the last decade. That's insane. Number of new drugs that are coming out, it's like chefs testing new recipes because it's all synthetic now. It's made in labs, and you can …
Get the full transcript (5,366 words) + summary by email — free
One-time email with the complete transcript and AI summary of this episode. No account needed.
One email, no spam. We’ll also show you what SignalCast does.
You just read a 3-minute summary of a 24-minute episode.
Get The Daily (NYT) summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from The Daily (NYT)
Canada Is Done With Trump
Aug 25 · 37 min
The Vergecast
What's really open about open-weight AI?
Aug 4
More from The Daily (NYT)
Natalie Harp’s Devotion to Trump
Aug 24 · 22 min
The Biotech Startups Podcast
🧬 You Don’t See the Path, You Take the Next Step | Sujal Patel (Part 4/4)
Mar 12
More from The Daily (NYT)
We summarize every new episode. Want them in your inbox?
Canada Is Done With Trump
Natalie Harp’s Devotion to Trump
Think Baseball Is Boring? The Savannah Bananas Are Here to Fix That.
An Expert on Conflict Says Your Relationships Are Doomed Without It
When Private Equity Comes for Your Favorite Team
Similar Episodes
Related episodes from other podcasts
Explore Related Topics
This podcast is featured in Best News Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into The Daily (NYT).
Every Monday, we deliver AI summaries of the latest episodes from The Daily (NYT) and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime